Digital Health Canada

Canada Disease Surveillance Systems Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Canada Disease Surveillance Systems Market Industry Trends and Forecast to 2034: Segmented by (Type, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Canada · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $581.8 Mn Placeholder estimate
Estimate 2025 $626.6 Mn 7.7% of the global market
Projected 2034 $1.22 Bn 95% Adds $595.0 Mn over 9 forecast years
CAGR 2025–2034 7.7% Faster than 8% of 100 Digital Health markets here
Key players 5 Companies profiled
  • Canada is 7.67% of the global market.
  • In North America, the largest is US at $3.59 Bn.
  • Fastest growing: Canada (this report) at 7.7% a year.
  • Canada ranks 2nd of 2 by size in North America.

Market size projection

Canada

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$595.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Disease Surveillance Systems Market market size by year, Canada
YearMarket sizeChange that yearSince 2025
2024 (estimate) $581.8 Mn — —
2025 (base) $626.6 Mn +$44.8 Mn —
2026 (forecast) $674.8 Mn +$48.2 Mn +7.7%
2027 (forecast) $726.8 Mn +$52.0 Mn +16%
2028 (forecast) $782.8 Mn +$56.0 Mn +24.9%
2029 (forecast) $843.0 Mn +$60.3 Mn +34.5%
2030 (forecast) $908.0 Mn +$64.9 Mn +44.9%
2031 (forecast) $977.9 Mn +$69.9 Mn +56.1%
2032 (forecast) $1.05 Bn +$75.3 Mn +68.1%
2033 (forecast) $1.13 Bn +$81.1 Mn +81%
2034 (forecast) $1.22 Bn +$87.3 Mn +95%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Canada Disease Surveillance Systems Market Analysis at a glance
Market size, 2025$626.6 Mn placeholder estimate
Forecast, 2034$1.22 Bn placeholder estimate
Growth (CAGR), 2025–20347.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType and user (see all)
Key playersSAS Institute, Biobot Analytics, Ginkgo Bioworks, BlueDot, Esri (see all)
Regulator in CanadaHealth CanadaSource: Health Canada. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Canada Disease Surveillance Systems Market Analysis Executive Summary

Disease surveillance systems collect and analyse data to spot outbreaks early and guide public health action.

Key segments of the disease Surveillance Systems market include type (Syndromic Surveillance, Lab-Based Surveillance and Genomic Surveillance) and user (Governments, WHO and NGOs and Hospitals).

Bar chart: Canada Disease Surveillance Systems market size, 2024–2034, placeholder estimates. $581.8 Mn in 2024, $626.6 Mn in 2025 and $1.22 Bn in 2034, 7.7% CAGR.
Canada Disease Surveillance Systems market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Canada Disease Surveillance Systems Market Dynamics

Market Growth Drivers

Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the disease Surveillance Systems market.

Opportunity

Digital tools for community health, local manufacturing and public-private partnerships give the disease Surveillance Systems market room to grow.

Market Restraints

Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the disease Surveillance Systems market.

Competitive Landscape for Disease Surveillance Systems Market in Canada

The disease Surveillance Systems market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Disease Surveillance Systems Market in Canada

Disease Surveillance Systems in Canada: rules and payment

Software that meets the definition of a medical device needs a Health Canada licence, based on its risk class.⁠[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.⁠[2]

[1] Health Canada. Checked 14 Nov 2026.

[2] Health Canada. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the disease Surveillance Systems market. Government digital health programs in Canada are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Disease Surveillance Systems right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Disease Surveillance Systems in context

Canada compared

  • Health spending per person: 6,378 US$ per person (2024). World: 1,317 US$ per person (2023).[1]
  • Doctors: 2.82 per 1,000 people (2023). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 20.3% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Disease Surveillance Systems market in Canada?
Placeholder estimate: about $626.6 Mn in 2025, rising to about $1.22 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Disease Surveillance Systems market in Canada growing?
Placeholder estimate: about 7.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Disease Surveillance Systems market report cover?
The report splits the market by type (Syndromic Surveillance, Lab-Based Surveillance, Genomic Surveillance, Wastewater Surveillance) and user (Governments, WHO and NGOs, Hospitals).
Who are the key players in the Disease Surveillance Systems market?
Key players include SAS Institute, Biobot Analytics, Ginkgo Bioworks, BlueDot and Esri.
What is driving the Disease Surveillance Systems market?
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the disease Surveillance Systems market.
Who regulates Disease Surveillance Systems in Canada?
Software that meets the definition of a medical device needs a Health Canada licence, based on its risk class. Source: Health Canada. Checked 14 Nov 2026.
How is healthcare paid for in Canada?
Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services. Source: Health Canada. Checked 14 Nov 2026.
How much research is published on Disease Surveillance Systems?
PubMed lists 172 papers on Disease Surveillance Systems added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Canada

See all

Related on infectious diseases and health it and data

See the topic